This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Other. Active years: 1980-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shelton, WA (US) (1980 - 1981)
- Branchburg, NJ (US) (2008 - 2013)
Company Filing History:
2 out of 2,100 
2 out of 363 
2 out of 834,453 Years Active: 1980-2013
Title: Christopher Norman Nilsen: Innovator in Serine Protease Inhibition
Introduction
Christopher Norman Nilsen is a notable inventor based in Branchburg, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of phosphonic acid compounds. With a total of six patents to his name, Nilsen's work focuses on innovative solutions for treating inflammatory and serine protease-mediated disorders.
Latest Patents
Nilsen's latest patents include groundbreaking inventions related to phosphonic acid compounds. These compounds are designed as inhibitors of serine proteases, which play a crucial role in various biological processes. His inventions not only provide compositions of these compounds but also outline methods for their application in treating specific medical conditions.
Career Highlights
Throughout his career, Christopher Nilsen has worked with prominent organizations, including Ortho-McNeil Pharmaceutical Corporation. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Nilsen has collaborated with several professionals in his field, including Kirk L. Sorgi and Michael Nicholas Greco. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Christopher Norman Nilsen stands out as a dedicated inventor whose work in serine protease inhibition has the potential to transform medical treatments. His innovative approach and collaboration with industry professionals highlight his commitment to advancing biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile